APO Research
Talk to an analyst

APO RESEARCH · REPORT

Rilpivirine

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Rilpivirine Market Analysis and Forecast 2026-2032

23 December 2025194 pages

Choose your research edition.

Industry ResearchRilpivirine Industry Research Report 2026117 pages · $2,950 USDIndustry Growth & TrendsGlobal Rilpivirine Industry Growth and Trends Forecast to 203298 pages · $3,450 USDMarket StructureGlobal Rilpivirine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032186 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Rilpivirine Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Rilpivirine Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Rilpivirine market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Rilpivirine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Rilpivirine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Rilpivirine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Rilpivirine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Rilpivirine include Aspen, Gilead Sciences, Janssen Cilag International, Pharmacare Limited, Strides Pharma Science Limited and ViiV Healthcare, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Rilpivirine, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Rilpivirine, also provides the sales of main regions and countries. Of the upcoming market potential for Rilpivirine, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Rilpivirine sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Rilpivirine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Rilpivirine sales, projected growth trends, production technology, application and end-user industry.

Rilpivirine Segment by Company

Aspen

Gilead Sciences

Janssen Cilag International

Pharmacare Limited

Strides Pharma Science Limited

ViiV Healthcare

Rilpivirine Segment by Type

Self-production API

Outsourcing of API

Rilpivirine Segment by Application

Clinic

Hospital

Drug Center

Others

Rilpivirine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Rilpivirine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Rilpivirine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Rilpivirine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Rilpivirine in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Rilpivirine manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Rilpivirine sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Rilpivirine Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Self-production API Major Manufacturers Table 3. Outsourcing of API Major Manufacturers Table 4. Global Rilpivirine Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Clinic Major Manufacturers Table 6. Hospital Major Manufacturers Table 7. Drug Center Major Manufacturers Table 8. Others Major Manufacturers Table 9. Rilpivirine Industry Trends Table 10. Rilpivirine Industry Drivers Table 11. Rilpivirine Industry Opportunities and Challenges Table 12. Rilpivirine Industry Restraints Table 13. Global Rilpivirine Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 14. Global Rilpivirine Revenue by Region (2021-2026) & (US$ Million) Table 15. Global Rilpivirine Revenue by Region (2027-2032) & (US$ Million) Table 16. Global Rilpivirine Revenue Market Share by Region (2021-2026) Table 17. Global Rilpivirine Revenue Market Share by Region (2027-2032) Table 18. Global Rilpivirine Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (k pcs) Table 19. Global Rilpivirine Sales by Region (2021-2026) & (k pcs) Table 20. Global Rilpivirine Sales by Region (2027-2032) & (k pcs) Table 21. Global Rilpivirine Sales Market Share by Region (2021-2026) Table 22. Global Rilpivirine Sales Market Share by Region (2027-2032) Table 23. Global Rilpivirine Revenue by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Rilpivirine Revenue Market Share by Manufacturers (2021-2026) Table 25. Global Rilpivirine Sales by Manufacturers (US$ Million) & (2021-2026) Table 26. Global Rilpivirine Sales Market Share by Manufacturers (2021-2026) Table 27. Global Rilpivirine Sales Price (US$/pcs) of Manufacturers (2021-2026) Table 28. Global Rilpivirine Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 29. Global Rilpivirine Key Manufacturers Manufacturing Sites & Headquarters Table 30. Global Rilpivirine Manufacturers, Product Type & Application Table 31. Global Rilpivirine Manufacturers' Establishment Date Table 32. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 33. Global Rilpivirine by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 34. Global Rilpivirine Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Rilpivirine Revenue by Type (2021-2026) & (US$ Million) Table 36. Global Rilpivirine Revenue by Type (2027-2032) & (US$ Million) Table 37. Global Rilpivirine Revenue Market Share by Type (2021-2026) Table 38. Global Rilpivirine Revenue Market Share by Type (2027-2032) Table 39. Global Rilpivirine Sales by Type 2021 VS 2025 VS 2032 (k pcs) Table 40. Global Rilpivirine Sales by Type (2021-2026) & (k pcs) Table 41. Global Rilpivirine Sales by Type (2027-2032) & (k pcs) Table 42. Global Rilpivirine Sales Market Share by Type (2021-2026) Table 43. Global Rilpivirine Sales Market Share by Type (2027-2032) Table 44. Global Rilpivirine Price by Type (2021-2026) & (US$/pcs) Table 45. Global Rilpivirine Price by Type (2027-2032) & (US$/pcs) Table 46. Global Rilpivirine Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Rilpivirine Revenue by Application (2021-2026) & (US$ Million) Table 48. Global Rilpivirine Revenue by Application (2027-2032) & (US$ Million) Table 49. Global Rilpivirine Revenue Market Share by Application (2021-2026) Table 50. Global Rilpivirine Revenue Market Share by Application (2027-2032) Table 51. Global Rilpivirine Sales by Application 2021 VS 2025 VS 2032 (k pcs) Table 52. Global Rilpivirine Sales by Application (2021-2026) & (k pcs) Table 53. Global Rilpivirine Sales by Application (2027-2032) & (k pcs) Table 54. Global Rilpivirine Sales Market Share by Application (2021-2026) Table 55. Global Rilpivirine Sales Market Share by Application (2027-2032) Table 56. Global Rilpivirine Price by Application (2021-2026) & (US$/pcs) Table 57. Global Rilpivirine Price by Application (2027-2032) & (US$/pcs) Table 58. Aspen Company Information Table 59. Aspen Business Overview Table 60. Aspen Rilpivirine Sales (k pcs), Revenue (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 61. Aspen Rilpivirine Product Portfolio Table 62. Aspen Recent Development Table 63. Gilead Sciences Company Information Table 64. Gilead Sciences Business Overview Table 65. Gilead Sciences Rilpivirine Sales (k pcs), Revenue (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 66. Gilead Sciences Rilpivirine Product Portfolio Table 67. Gilead Sciences Recent Development Table 68. Janssen Cilag International Company Information Table 69. Janssen Cilag International Business Overview Table 70. Janssen Cilag International Rilpivirine Sales (k pcs), Revenue (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 71. Janssen Cilag International Rilpivirine Product Portfolio Table 72. Janssen Cilag International Recent Development Table 73. Pharmacare Limited Company Information Table 74. Pharmacare Limited Business Overview Table 75. Pharmacare Limited Rilpivirine Sales (k pcs), Revenue (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 76. Pharmacare Limited Rilpivirine Product Portfolio Table 77. Pharmacare Limited Recent Development Table 78. Strides Pharma Science Limited Company Information Table 79. Strides Pharma Science Limited Business Overview Table 80. Strides Pharma Science Limited Rilpivirine Sales (k pcs), Revenue (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 81. Strides Pharma Science Limited Rilpivirine Product Portfolio Table 82. Strides Pharma Science Limited Recent Development Table 83. ViiV Healthcare Company Information Table 84. ViiV Healthcare Business Overview Table 85. ViiV Healthcare Rilpivirine Sales (k pcs), Revenue (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 86. ViiV Healthcare Rilpivirine Product Portfolio Table 87. ViiV Healthcare Recent Development Table 88. North America Rilpivirine Revenue by Type (2021-2026) & (US$ Million) Table 89. North America Rilpivirine Revenue by Type (2027-2032) & (US$ Million) Table 90. North America Rilpivirine Sales by Type (2021-2026) & (k pcs) Table 91. North America Rilpivirine Sales by Type (2027-2032) & (k pcs) Table 92. North America Rilpivirine Sales Price by Type (2021-2026) & (US$/pcs) Table 93. North America Rilpivirine Sales Price by Type (2027-2032) & (US$/pcs) Table 94. North America Rilpivirine Revenue by Application (2021-2026) & (US$ Million) Table 95. North America Rilpivirine Revenue by Application (2027-2032) & (US$ Million) Table 96. North America Rilpivirine Sales by Application (2021-2026) & (k pcs) Table 97. North America Rilpivirine Sales by Application (2027-2032) & (k pcs) Table 98. North America Rilpivirine Sales Price by Application (2021-2026) & (US$/pcs) Table 99. North America Rilpivirine Sales Price by Application (2027-2032) & (US$/pcs) Table 100. North America Rilpivirine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 101. North America Rilpivirine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 102. North America Rilpivirine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 103. North America Rilpivirine Sales by Country (2021 VS 2025 VS 2032) & (k pcs) Table 104. North America Rilpivirine Sales by Country (2021-2026) & (k pcs) Table 105. North America Rilpivirine Sales by Country (2027-2032) & (k pcs) Table 106. North America Rilpivirine Sales Price by Country (2021-2026) & (US$/pcs) Table 107. North America Rilpivirine Sales Price by Country (2027-2032) & (US$/pcs) Table 108. United States Rilpivirine Revenue (2021-2032) & (US$ Million) Table 109. Canada Rilpivirine Revenue (2021-2032) & (US$ Million) Table 110. Mexico Rilpivirine Revenue (2021-2032) & (US$ Million) Table 111. Europe Rilpivirine Revenue by Type (2021-2026) & (US$ Million) Table 112. Europe Rilpivirine Revenue by Type (2027-2032) & (US$ Million) Table 113. Europe Rilpivirine Sales by Type (2021-2026) & (k pcs) Table 114. Europe Rilpivirine Sales by Type (2027-2032) & (k pcs) Table 115. Europe Rilpivirine Sales Price by Type (2021-2026) & (US$/pcs) Table 116. Europe Rilpivirine Sales Price by Type (2027-2032) & (US$/pcs) Table 117. Europe Rilpivirine Revenue by Application (2021-2026) & (US$ Million) Table 118. Europe Rilpivirine Revenue by Application (2027-2032) & (US$ Million) Table 119. Europe Rilpivirine Sales by Application (2021-2026) & (k pcs) Table 120. Europe Rilpivirine Sales by Application (2027-2032) & (k pcs) Table 121. Europe Rilpivirine Sales Price by Application (2021-2026) & (US$/pcs) Table 122. Europe Rilpivirine Sales Price by Application (2027-2032) & (US$/pcs) Table 123. Europe Rilpivirine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 124. Europe Rilpivirine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 125. Europe Rilpivirine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 126. Europe Rilpivirine Sales by Country (2021 VS 2025 VS 2032) & (k pcs) Table 127. Europe Rilpivirine Sales by Country (2021-2026) & (k pcs) Table 128. Europe Rilpivirine Sales by Country (2027-2032) & (k pcs) Table 129. Europe Rilpivirine Sales Price by Country (2021-2026) & (US$/pcs) Table 130. Europe Rilpivirine Sales Price by Country (2027-2032) & (US$/pcs) Table 131. Germany Rilpivirine Revenue (2021-2032) & (US$ Million) Table 132. France Rilpivirine Revenue (2021-2032) & (US$ Million) Table 133. U.K. Rilpivirine Revenue (2021-2032) & (US$ Million) Table 134. Italy Rilpivirine Revenue (2021-2032) & (US$ Million) Table 135. Russia Rilpivirine Revenue (2021-2032) & (US$ Million) Table 136. Spain Rilpivirine Revenue (2021-2032) & (US$ Million) Table 137. Netherlands Rilpivirine Revenue (2021-2032) & (US$ Million) Table 138. Switzerland Rilpivirine Revenue (2021-2032) & (US$ Million) Table 139. Sweden Rilpivirine Revenue (2021-2032) & (US$ Million) Table 140. Poland Rilpivirine Revenue (2021-2032) & (US$ Million) Table 141. China Rilpivirine Revenue by Type (2021-2026) & (US$ Million) Table 142. China Rilpivirine Revenue by Type (2027-2032) & (US$ Million) Table 143. China Rilpivirine Sales by Type (2021-2026) & (k pcs) Table 144. China Rilpivirine Sales by Type (2027-2032) & (k pcs) Table 145. China Rilpivirine Sales Price by Type (2021-2026) & (US$/pcs) Table 146. China Rilpivirine Sales Price by Type (2027-2032) & (US$/pcs) Table 147. China Rilpivirine Revenue by Application (2021-2026) & (US$ Million) Table 148. China Rilpivirine Revenue by Application (2027-2032) & (US$ Million) Table 149. China Rilpivirine Sales by Application (2021-2026) & (k pcs) Table 150. China Rilpivirine Sales by Application (2027-2032) & (k pcs) Table 151. China Rilpivirine Sales Price by Application (2021-2026) & (US$/pcs) Table 152. China Rilpivirine Sales Price by Application (2027-2032) & (US$/pcs) Table 153. Asia Rilpivirine Revenue by Type (2021-2026) & (US$ Million) Table 154. Asia Rilpivirine Revenue by Type (2027-2032) & (US$ Million) Table 155. Asia Rilpivirine Sales by Type (2021-2026) & (k pcs) Table 156. Asia Rilpivirine Sales by Type (2027-2032) & (k pcs) Table 157. Asia Rilpivirine Sales Price by Type (2021-2026) & (US$/pcs) Table 158. Asia Rilpivirine Sales Price by Type (2027-2032) & (US$/pcs) Table 159. Asia Rilpivirine Revenue by Application (2021-2026) & (US$ Million) Table 160. Asia Rilpivirine Revenue by Application (2027-2032) & (US$ Million) Table 161. Asia Rilpivirine Sales by Application (2021-2026) & (k pcs) Table 162. Asia Rilpivirine Sales by Application (2027-2032) & (k pcs) Table 163. Asia Rilpivirine Sales Price by Application (2021-2026) & (US$/pcs) Table 164. Asia Rilpivirine Sales Price by Application (2027-2032) & (US$/pcs) Table 165. Asia Rilpivirine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 166. Asia Rilpivirine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 167. Asia Rilpivirine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 168. Asia Rilpivirine Sales by Country (2021 VS 2025 VS 2032) & (k pcs) Table 169. Asia Rilpivirine Sales by Country (2021-2026) & (k pcs) Table 170. Asia Rilpivirine Sales by Country (2027-2032) & (k pcs) Table 171. Asia Rilpivirine Sales Price by Country (2021-2026) & (US$/pcs) Table 172. Asia Rilpivirine Sales Price by Country (2027-2032) & (US$/pcs) Table 173. Japan Rilpivirine Revenue (2021-2032) & (US$ Million) Table 174. South Korea Rilpivirine Revenue (2021-2032) & (US$ Million) Table 175. India Rilpivirine Revenue (2021-2032) & (US$ Million) Table 176. Australia Rilpivirine Revenue (2021-2032) & (US$ Million) Table 177. Taiwan Rilpivirine Revenue (2021-2032) & (US$ Million) Table 178. Southeast Asia Rilpivirine Revenue (2021-2032) & (US$ Million) Table 179. SAMEA Rilpivirine Revenue by Type (2021-2026) & (US$ Million) Table 180. SAMEA Rilpivirine Revenue by Type (2027-2032) & (US$ Million) Table 181. SAMEA Rilpivirine Sales by Type (2021-2026) & (k pcs) Table 182. SAMEA Rilpivirine Sales by Type (2027-2032) & (k pcs) Table 183. SAMEA Rilpivirine Sales Price by Type (2021-2026) & (US$/pcs) Table 184. SAMEA Rilpivirine Sales Price by Type (2027-2032) & (US$/pcs) Table 185. SAMEA Rilpivirine Revenue by Application (2021-2026) & (US$ Million) Table 186. SAMEA Rilpivirine Revenue by Application (2027-2032) & (US$ Million) Table 187. SAMEA Rilpivirine Sales by Application (2021-2026) & (k pcs) Table 188. SAMEA Rilpivirine Sales by Application (2027-2032) & (k pcs) Table 189. SAMEA Rilpivirine Sales Price by Application (2021-2026) & (US$/pcs) Table 190. SAMEA Rilpivirine Sales Price by Application (2027-2032) & (US$/pcs) Table 191. SAMEA Rilpivirine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 192. SAMEA Rilpivirine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 193. SAMEA Rilpivirine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 194. SAMEA Rilpivirine Sales by Country (2021 VS 2025 VS 2032) & (k pcs) Table 195. SAMEA Rilpivirine Sales by Country (2021-2026) & (k pcs) Table 196. SAMEA Rilpivirine Sales by Country (2027-2032) & (k pcs) Table 197. SAMEA Rilpivirine Sales Price by Country (2021-2026) & (US$/pcs) Table 198. SAMEA Rilpivirine Sales Price by Country (2027-2032) & (US$/pcs) Table 199. Brazil Rilpivirine Revenue (2021-2032) & (US$ Million) Table 200. Argentina Rilpivirine Revenue (2021-2032) & (US$ Million) Table 201. Chile Rilpivirine Revenue (2021-2032) & (US$ Million) Table 202. Colombia Rilpivirine Revenue (2021-2032) & (US$ Million) Table 203. Peru Rilpivirine Revenue (2021-2032) & (US$ Million) Table 204. Saudi Arabia Rilpivirine Revenue (2021-2032) & (US$ Million) Table 205. Israel Rilpivirine Revenue (2021-2032) & (US$ Million) Table 206. UAE Rilpivirine Revenue (2021-2032) & (US$ Million) Table 207. Turkey Rilpivirine Revenue (2021-2032) & (US$ Million) Table 208. Iran Rilpivirine Revenue (2021-2032) & (US$ Million) Table 209. Egypt Rilpivirine Revenue (2021-2032) & (US$ Million) Table 210. Key Raw Materials Table 211. Raw Materials Key Suppliers Table 212. Rilpivirine Distributors List Table 213. Rilpivirine Customers List Table 214. Research Programs/Design for This Report Table 215. Authors List of This Report Table 216. Secondary Sources Table 217. Primary Sources List of Figures Figure 1. Rilpivirine Image Figure 2. Global Rilpivirine Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Rilpivirine Market Size Share 2021 VS 2025 VS 2032 Figure 4. Self-production API Image Figure 5. Outsourcing of API Image Figure 6. Global Rilpivirine Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Rilpivirine Market Size Share 2021 VS 2025 VS 2032 Figure 8. Clinic Image Figure 9. Hospital Image Figure 10. Drug Center Image Figure 11. Others Image Figure 12. Global Rilpivirine Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Rilpivirine Revenue (2021-2032) & (US$ Million) Figure 14. Global Rilpivirine Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 15. Global Rilpivirine Revenue Market Share by Region: 2025 Versus 2032 Figure 16. Global Rilpivirine Revenue Market Share by Region (2021-2032) Figure 17. Global Rilpivirine Sales (2021-2032) & (k pcs) Figure 18. Global Rilpivirine Sales by Region: 2021 VS 2025 VS 2032 (k pcs) Figure 19. Global Rilpivirine Sales Market Share by Region (2021-2032) Figure 20. US & Canada & Mexico Rilpivirine Sales YoY (2021-2032) & (k pcs) Figure 21. Europe Rilpivirine Sales YoY (2021-2032) & (k pcs) Figure 22. China Rilpivirine Sales YoY (2021-2032) & (k pcs) Figure 23. Asia (Excluding China) Rilpivirine Sales YoY (2021-2032) & (k pcs) Figure 24. South America, Middle East and Africa Rilpivirine Sales YoY (2021-2032) & (k pcs) Figure 25. Global Rilpivirine Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 26. Global Rilpivirine Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 27. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 28. Global Rilpivirine Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 29. Global Rilpivirine Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 30. Global Rilpivirine Revenue Market Share by Type (2021-2032) Figure 31. Global Rilpivirine Sales by Type (2021 VS 2025 VS 2032) & (k pcs) Figure 32. Global Rilpivirine Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 33. Global Rilpivirine Sales Market Share by Type (2021-2032) Figure 34. Global Rilpivirine Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 35. Global Rilpivirine Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 36. Global Rilpivirine Revenue Market Share by Application (2021-2032) Figure 37. Global Rilpivirine Sales by Application (2021 VS 2025 VS 2032) & (k pcs) Figure 38. Global Rilpivirine Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 39. Global Rilpivirine Sales Market Share by Application (2021-2032) Figure 40. North America Rilpivirine Revenue Share by Type (2021-2032) Figure 41. North America Rilpivirine Sales Share by Type (2021-2032) Figure 42. North America Rilpivirine Revenue Share by Application (2021-2032) Figure 43. North America Rilpivirine Sales Share by Application (2021-2032) Figure 44. North America Rilpivirine Revenue Share by Country (2021-2032) Figure 45. North America Rilpivirine Sales Share by Country (2021-2032) Figure 46. Europe Rilpivirine Revenue Share by Type (2021-2032) Figure 47. Europe Rilpivirine Sales Share by Type (2021-2032) Figure 48. Europe Rilpivirine Revenue Share by Application (2021-2032) Figure 49. Europe Rilpivirine Sales Share by Application (2021-2032) Figure 50. Europe Rilpivirine Revenue Share by Country (2021-2032) Figure 51. Europe Rilpivirine Sales Share by Country (2021-2032) Figure 52. China Rilpivirine Revenue Share by Type (2021-2032) Figure 53. China Rilpivirine Sales Share by Type (2021-2032) Figure 54. China Rilpivirine Revenue Share by Application (2021-2032) Figure 55. China Rilpivirine Sales Share by Application (2021-2032) Figure 56. Asia Rilpivirine Revenue Share by Type (2021-2032) Figure 57. Asia Rilpivirine Sales Share by Type (2021-2032) Figure 58. Asia Rilpivirine Revenue Share by Application (2021-2032) Figure 59. Asia Rilpivirine Sales Share by Application (2021-2032) Figure 60. Asia Rilpivirine Revenue Share by Country (2021-2032) Figure 61. Asia Rilpivirine Sales Share by Country (2021-2032) Figure 62. SAMEA Rilpivirine Revenue Share by Type (2021-2032) Figure 63. SAMEA Rilpivirine Sales Share by Type (2021-2032) Figure 64. SAMEA Rilpivirine Revenue Share by Application (2021-2032) Figure 65. SAMEA Rilpivirine Sales Share by Application (2021-2032) Figure 66. SAMEA Rilpivirine Revenue Share by Country (2021-2032) Figure 67. SAMEA Rilpivirine Sales Share by Country (2021-2032) Figure 68. Rilpivirine Value Chain Figure 69. Manufacturing Cost Structure Figure 70. Rilpivirine Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Self-production API
  • Outsourcing of API
Applications
  • Clinic
  • Hospital
  • Drug Center
  • Others
Companies covered
  • Aspen
  • Gilead Sciences
  • Janssen Cilag International
  • Pharmacare Limited
  • Strides Pharma Science Limited
  • ViiV Healthcare

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Rilpivirine Market by Type
  3. 1.2.1 Global Rilpivirine Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Self-production API
  5. 1.2.3 Outsourcing of API
  6. 1.3 Rilpivirine Market by Application
  7. 1.3.1 Global Rilpivirine Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Clinic
  9. 1.3.3 Hospital
  10. 1.3.4 Drug Center
  11. 1.3.5 Others
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Rilpivirine Market Dynamics
  1. 2.1 Rilpivirine Industry Trends
  2. 2.2 Rilpivirine Industry Drivers
  3. 2.3 Rilpivirine Industry Opportunities and Challenges
  4. 2.4 Rilpivirine Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Rilpivirine Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Rilpivirine Revenue by Region
  3. 3.2.1 Global Rilpivirine Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Rilpivirine Revenue by Region (2021-2026)
  5. 3.2.3 Global Rilpivirine Revenue by Region (2027-2032)
  6. 3.2.4 Global Rilpivirine Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Rilpivirine Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Rilpivirine Sales by Region
  9. 3.4.1 Global Rilpivirine Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Rilpivirine Sales by Region (2021-2026)
  11. 3.4.3 Global Rilpivirine Sales by Region (2027-2032)
  12. 3.4.4 Global Rilpivirine Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Rilpivirine Revenue by Manufacturers
  2. 4.1.1 Global Rilpivirine Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Rilpivirine Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Rilpivirine Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Rilpivirine Sales by Manufacturers
  6. 4.2.1 Global Rilpivirine Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Rilpivirine Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Rilpivirine Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Rilpivirine Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Rilpivirine Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Rilpivirine Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Rilpivirine Manufacturers, Product Type & Application
  13. 4.7 Global Rilpivirine Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Rilpivirine Market CR5 and HHI
  16. 4.8.2 2025 Rilpivirine Tier 1, Tier 2, and Tier 3
5 Rilpivirine Market by Type
  1. 5.1 Global Rilpivirine Revenue by Type
  2. 5.1.1 Global Rilpivirine Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Rilpivirine Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Rilpivirine Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Rilpivirine Sales by Type
  6. 5.2.1 Global Rilpivirine Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Rilpivirine Sales by Type (2021-2032) & (k pcs)
  8. 5.2.3 Global Rilpivirine Sales Market Share by Type (2021-2032)
  9. 5.3 Global Rilpivirine Price by Type
6 Rilpivirine Market by Application
  1. 6.1 Global Rilpivirine Revenue by Application
  2. 6.1.1 Global Rilpivirine Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Rilpivirine Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Rilpivirine Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Rilpivirine Sales by Application
  6. 6.2.1 Global Rilpivirine Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Rilpivirine Sales by Application (2021-2032) & (k pcs)
  8. 6.2.3 Global Rilpivirine Sales Market Share by Application (2021-2032)
  9. 6.3 Global Rilpivirine Price by Application
7 Company Profiles
  1. 7.1 Aspen
  2. 7.1.1 Aspen Company Information
  3. 7.1.2 Aspen Business Overview
  4. 7.1.3 Aspen Rilpivirine Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Aspen Rilpivirine Product Portfolio
  6. 7.1.5 Aspen Recent Developments
  7. 7.2 Gilead Sciences
  8. 7.2.1 Gilead Sciences Company Information
  9. 7.2.2 Gilead Sciences Business Overview
  10. 7.2.3 Gilead Sciences Rilpivirine Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Gilead Sciences Rilpivirine Product Portfolio
  12. 7.2.5 Gilead Sciences Recent Developments
  13. 7.3 Janssen Cilag International
  14. 7.3.1 Janssen Cilag International Company Information
  15. 7.3.2 Janssen Cilag International Business Overview
  16. 7.3.3 Janssen Cilag International Rilpivirine Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Janssen Cilag International Rilpivirine Product Portfolio
  18. 7.3.5 Janssen Cilag International Recent Developments
  19. 7.4 Pharmacare Limited
  20. 7.4.1 Pharmacare Limited Company Information
  21. 7.4.2 Pharmacare Limited Business Overview
  22. 7.4.3 Pharmacare Limited Rilpivirine Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Pharmacare Limited Rilpivirine Product Portfolio
  24. 7.4.5 Pharmacare Limited Recent Developments
  25. 7.5 Strides Pharma Science Limited
  26. 7.5.1 Strides Pharma Science Limited Company Information
  27. 7.5.2 Strides Pharma Science Limited Business Overview
  28. 7.5.3 Strides Pharma Science Limited Rilpivirine Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Strides Pharma Science Limited Rilpivirine Product Portfolio
  30. 7.5.5 Strides Pharma Science Limited Recent Developments
  31. 7.6 ViiV Healthcare
  32. 7.6.1 ViiV Healthcare Company Information
  33. 7.6.2 ViiV Healthcare Business Overview
  34. 7.6.3 ViiV Healthcare Rilpivirine Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 ViiV Healthcare Rilpivirine Product Portfolio
  36. 7.6.5 ViiV Healthcare Recent Developments
8 North America
  1. 8.1 North America Rilpivirine Market Size by Type
  2. 8.1.1 North America Rilpivirine Revenue by Type (2021-2032)
  3. 8.1.2 North America Rilpivirine Sales by Type (2021-2032)
  4. 8.1.3 North America Rilpivirine Price by Type (2021-2032)
  5. 8.2 North America Rilpivirine Market Size by Application
  6. 8.2.1 North America Rilpivirine Revenue by Application (2021-2032)
  7. 8.2.2 North America Rilpivirine Sales by Application (2021-2032)
  8. 8.2.3 North America Rilpivirine Price by Application (2021-2032)
  9. 8.3 North America Rilpivirine Market Size by Country
  10. 8.3.1 North America Rilpivirine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Rilpivirine Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Rilpivirine Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Rilpivirine Market Size by Type
  2. 9.1.1 Europe Rilpivirine Revenue by Type (2021-2032)
  3. 9.1.2 Europe Rilpivirine Sales by Type (2021-2032)
  4. 9.1.3 Europe Rilpivirine Price by Type (2021-2032)
  5. 9.2 Europe Rilpivirine Market Size by Application
  6. 9.2.1 Europe Rilpivirine Revenue by Application (2021-2032)
  7. 9.2.2 Europe Rilpivirine Sales by Application (2021-2032)
  8. 9.2.3 Europe Rilpivirine Price by Application (2021-2032)
  9. 9.3 Europe Rilpivirine Market Size by Country
  10. 9.3.1 Europe Rilpivirine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Rilpivirine Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Rilpivirine Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Rilpivirine Market Size by Type
  2. 10.1.1 China Rilpivirine Revenue by Type (2021-2032)
  3. 10.1.2 China Rilpivirine Sales by Type (2021-2032)
  4. 10.1.3 China Rilpivirine Price by Type (2021-2032)
  5. 10.2 China Rilpivirine Market Size by Application
  6. 10.2.1 China Rilpivirine Revenue by Application (2021-2032)
  7. 10.2.2 China Rilpivirine Sales by Application (2021-2032)
  8. 10.2.3 China Rilpivirine Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Rilpivirine Market Size by Type
  2. 11.1.1 Asia Rilpivirine Revenue by Type (2021-2032)
  3. 11.1.2 Asia Rilpivirine Sales by Type (2021-2032)
  4. 11.1.3 Asia Rilpivirine Price by Type (2021-2032)
  5. 11.2 Asia Rilpivirine Market Size by Application
  6. 11.2.1 Asia Rilpivirine Revenue by Application (2021-2032)
  7. 11.2.2 Asia Rilpivirine Sales by Application (2021-2032)
  8. 11.2.3 Asia Rilpivirine Price by Application (2021-2032)
  9. 11.3 Asia Rilpivirine Market Size by Country
  10. 11.3.1 Asia Rilpivirine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Rilpivirine Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Rilpivirine Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Rilpivirine Market Size by Type
  2. 12.1.1 SAMEA Rilpivirine Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Rilpivirine Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Rilpivirine Price by Type (2021-2032)
  5. 12.2 SAMEA Rilpivirine Market Size by Application
  6. 12.2.1 SAMEA Rilpivirine Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Rilpivirine Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Rilpivirine Price by Application (2021-2032)
  9. 12.3 SAMEA Rilpivirine Market Size by Country
  10. 12.3.1 SAMEA Rilpivirine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Rilpivirine Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Rilpivirine Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Rilpivirine Value Chain Analysis
  2. 13.1.1 Rilpivirine Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Rilpivirine Production Mode & Process
  6. 13.2 Rilpivirine Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Rilpivirine Distributors
  9. 13.2.3 Rilpivirine Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst